These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
341 related articles for article (PubMed ID: 15040005)
1. SHP-2 regulates the phosphatidylinositide 3'-kinase/Akt pathway and suppresses caspase 3-mediated apoptosis. Ivins Zito C; Kontaridis MI; Fornaro M; Feng GS; Bennett AM J Cell Physiol; 2004 May; 199(2):227-36. PubMed ID: 15040005 [TBL] [Abstract][Full Text] [Related]
2. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors. Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409 [TBL] [Abstract][Full Text] [Related]
3. Phosphatidylinositol 3-kinase (PI-3K)/Akt but not PI-3K/p70 S6 kinase signaling mediates IGF-1-promoted lens epithelial cell survival. Chandrasekher G; Sailaja D Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3577-88. PubMed ID: 15452065 [TBL] [Abstract][Full Text] [Related]
4. SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways. Ruhul Amin AR; Oo ML; Senga T; Suzuki N; Feng GS; Hamaguchi M Cancer Res; 2003 Oct; 63(19):6334-9. PubMed ID: 14559821 [TBL] [Abstract][Full Text] [Related]
5. The N-terminal SH2 domain of the tyrosine phosphatase, SHP-2, is essential for Jak2-dependent signaling via the angiotensin II type AT1 receptor. Godeny MD; Sayyah J; VonDerLinden D; Johns M; Ostrov DA; Caldwell-Busby J; Sayeski PP Cell Signal; 2007 Mar; 19(3):600-9. PubMed ID: 17027227 [TBL] [Abstract][Full Text] [Related]
6. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells. Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248 [TBL] [Abstract][Full Text] [Related]
7. Formation of distinct signalling complexes involving phosphatidylinositol 3-kinase activity with stimulation of epidermal growth factor or insulin-like growth factor-I in human skin fibroblasts. Takahashi Y; Akanuma Y; Yazaki Y; Kadowaki T J Cell Physiol; 1999 Jan; 178(1):69-75. PubMed ID: 9886492 [TBL] [Abstract][Full Text] [Related]
8. The Shp-2 tyrosine phosphatase activates the Src tyrosine kinase by a non-enzymatic mechanism. Walter AO; Peng ZY; Cartwright CA Oncogene; 1999 Mar; 18(11):1911-20. PubMed ID: 10208413 [TBL] [Abstract][Full Text] [Related]
9. Negative regulation of myeloid cell proliferation and function by the SH2 domain-containing tyrosine phosphatase-1. Dong Q; Siminovitch KA; Fialkow L; Fukushima T; Downey GP J Immunol; 1999 Mar; 162(6):3220-30. PubMed ID: 10092773 [TBL] [Abstract][Full Text] [Related]
10. Shp-2 has a positive regulatory role in ES cell differentiation and proliferation. Qu CK; Feng GS Oncogene; 1998 Jul; 17(4):433-9. PubMed ID: 9696036 [TBL] [Abstract][Full Text] [Related]
11. Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling. Paling NR; Welham MJ Biochem J; 2002 Dec; 368(Pt 3):885-94. PubMed ID: 12220225 [TBL] [Abstract][Full Text] [Related]
12. ROS fusion tyrosine kinase activates a SH2 domain-containing phosphatase-2/phosphatidylinositol 3-kinase/mammalian target of rapamycin signaling axis to form glioblastoma in mice. Charest A; Wilker EW; McLaughlin ME; Lane K; Gowda R; Coven S; McMahon K; Kovach S; Feng Y; Yaffe MB; Jacks T; Housman D Cancer Res; 2006 Aug; 66(15):7473-81. PubMed ID: 16885344 [TBL] [Abstract][Full Text] [Related]
13. SHP-1 sensitizes MCF-7 cells to trichostatin A-induced apoptosis by modulating PI3K-dependent events. Xu Y; Mousseau DD; Banville D; Zhao X; Shen SH Cell Death Differ; 2003 Oct; 10(10):1213-4. PubMed ID: 14502244 [No Abstract] [Full Text] [Related]
15. IGF-1 protects oligodendrocyte progenitors against TNFalpha-induced damage by activation of PI3K/Akt and interruption of the mitochondrial apoptotic pathway. Pang Y; Zheng B; Fan LW; Rhodes PG; Cai Z Glia; 2007 Aug; 55(11):1099-107. PubMed ID: 17577243 [TBL] [Abstract][Full Text] [Related]
16. IL-7 inhibits dexamethasone-induced apoptosis via Akt/PKB in mature, peripheral T cells. Sade H; Sarin A Eur J Immunol; 2003 Apr; 33(4):913-9. PubMed ID: 12672057 [TBL] [Abstract][Full Text] [Related]
17. SHP-1 negatively regulates neuronal survival by functioning as a TrkA phosphatase. Marsh HN; Dubreuil CI; Quevedo C; Lee A; Majdan M; Walsh GS; Hausdorff S; Said FA; Zoueva O; Kozlowski M; Siminovitch K; Neel BG; Miller FD; Kaplan DR J Cell Biol; 2003 Dec; 163(5):999-1010. PubMed ID: 14662744 [TBL] [Abstract][Full Text] [Related]
18. The tyrosine phosphatase, SHP-1, is a negative regulator of endothelial superoxide formation. Krötz F; Engelbrecht B; Buerkle MA; Bassermann F; Bridell H; Gloe T; Duyster J; Pohl U; Sohn HY J Am Coll Cardiol; 2005 May; 45(10):1700-6. PubMed ID: 15893190 [TBL] [Abstract][Full Text] [Related]
19. Abnormal mesoderm patterning in mouse embryos mutant for the SH2 tyrosine phosphatase Shp-2. Saxton TM; Henkemeyer M; Gasca S; Shen R; Rossi DJ; Shalaby F; Feng GS; Pawson T EMBO J; 1997 May; 16(9):2352-64. PubMed ID: 9171349 [TBL] [Abstract][Full Text] [Related]
20. Intracellular mechanisms mediating tocotrienol-induced apoptosis in neoplastic mammary epithelial cells. Sylvester PW; Shah S Asia Pac J Clin Nutr; 2005; 14(4):366-73. PubMed ID: 16326643 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]